ProSomnus Contributes Two Scientific Abstracts for Presentation at SLEEP 2024, A Joint Meeting of the American Academy of Sleep Medicine and the Sleep Research Society
May 30, 2024 06:00 ET
|
ProSomnus Sleep Technologies, Inc.
ProSomnus Contributes Two Scientific Abstracts for Presentation at SLEEP 2024
Dermatology Specialists of Florida to Open New Office in Niceville Florida
May 29, 2024 18:00 ET
|
Dermatology Specialists
Panama City, May 29, 2024 (GLOBE NEWSWIRE) -- Panama City, Florida - Dermatology Specialists of Florida is excited to announce the opening of a new clinic in Niceville, Florida, bringing...
Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024
May 29, 2024 07:00 ET
|
Axsome Therapeutics, Inc.
NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data At 2024 Eastern Allergy Conference
May 28, 2024 08:00 ET
|
Aquestive Therapeutics, Inc.
WARREN, N.J., May 28, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful...
Apnimed Announces a Robust Slate of Presentations at SLEEP 2024, Including an Analysis of the Prevalence of Obesity in Obstructive Sleep Apnea
May 23, 2024 09:50 ET
|
Apnimed, Inc.
Apnimed Announces a Robust Slate of Presentations at SLEEP 2024, Including an Analysis of the Prevalence of Obesity in Obstructive Sleep Apnea
Nexalin America Selected to Join the National Traumatic Brain Injury Registry Coalition to Propel TBI Awareness and Research Efforts
May 22, 2024 08:30 ET
|
Nexalin Technology, Inc.
HOUSTON, TX, May 22, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased to announce its new division, Nexalin America, has been selected...
Avadel Pharmaceuticals Shares New LUMRYZ™ (sodium oxybate) For Extended-release Oral Suspension (CIII) Data at SLEEP 2024
May 22, 2024 08:00 ET
|
Avadel Pharmaceuticals plc
– 11 accepted abstracts, including new data reiterating satisfaction, preference and clinical benefit of LUMRYZ – – Presentations highlight Avadel’s continued commitment to address gaps in...
mHealth Services (Monitoring, Diagnosis) Market Trends Analysis Report 2024-2030 Featuring Apple, Google, AirStrip, Samsung, Veradigm, Qualcomm, Vodafone, AT&T, Telefonica, SoftServe, Orange
May 21, 2024 09:36 ET
|
Research and Markets
Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The "mHealth Services Market Size, Share & Trends Analysis Report By Services (Monitoring Services, Diagnosis Services), By Participants, By Application,...
Motor Neuron Disease Clinical Trial Pipeline Appears Robust With 120+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
May 16, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, May 16, 2024 (GLOBE NEWSWIRE) -- Motor Neuron Disease Clinical Trial Pipeline Appears Robust With 120+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight...
ENT and Allergy Associates Reinforces Its Commitment to Future Growth by Welcoming Eight New Specialists in 2024
May 16, 2024 05:00 ET
|
ENT & Allergy Associates
Tarrytown, New York, May 16, 2024 (GLOBE NEWSWIRE) -- ENT and Allergy Associates, LLP (ENTA) is excited to welcome eight highly-skilled physicians to their team throughout Summer and Fall of 2024....